Neurodevelopmental Outcomes of Prenatal Preeclampsia Exposure

被引:102
|
作者
Gumusoglu, Serena B. [1 ]
Chilukuri, Akanksha S. S. [1 ]
Santillan, Donna A. [2 ]
Santillan, Mark K. [2 ]
Stevens, Hanna E. [1 ]
机构
[1] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Obstet & Gynecol, Carver Coll Med, Iowa City, IA 52242 USA
关键词
REDUCED UTERINE PERFUSION; AUTISM-SPECTRUM DISORDER; MATERNAL HYPERTENSIVE DISORDERS; FETAL-GROWTH RESTRICTION; NORMAL ANXIETY-LIKE; OXIDATIVE STRESS; CHILDREN BORN; PLACENTAL INSUFFICIENCY; COGNITIVE FUNCTION; BLOOD-PRESSURE;
D O I
10.1016/j.tins.2020.02.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Preeclampsia is a dangerous hypertensive disorder of pregnancy with known links to negative child health outcomes. Here, we review epidemiological and basic neuroscience work from the past several decades linking prenatal preeclampsia to altered neurodevelopment. This work demonstrates increased rates of neuropsychiatric disorders [e.g., increased autism spectrum disorder, attention deficit hyperactivity disorder (ADHD)] in children of preeclamptic pregnancies, as well as increased rates of cognitive impairments [e.g., decreased intelligence quotient (IQ), academic performance] and neurological disease (e.g., stroke and epilepsy). We also review findings from multiple animal models of preeclampsia. Manipulation of key clinical preeclampsia processes in these models (e.g., placental hypoxia, immune dysfunction, angiogenesis, oxidative stress) causes various disruptions in offspring, including ones in white matter/glia, glucocorticoid receptors, neuroimmune outcomes, cerebrovascular structure, and cognition/behavior. This animal work implicates potentially high-yield targets that may be leveraged in the future for clinical application.
引用
收藏
页码:253 / 268
页数:16
相关论文
共 50 条
  • [1] Prenatal Opioid Exposure and Neurodevelopmental Outcomes
    Lee, Jennifer J.
    Saraiya, Neeta
    Kuzniewicz, Michael W.
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2023, 35 (01) : 142 - 146
  • [2] Neurodevelopmental outcomes and prenatal exposure to marijuana
    Alvarez, Ana V. Gutierrez
    Rubin, David
    Pina, Paulo
    Velasquez, Michael Sorto
    PEDIATRICS, 2018, 142
  • [3] Prenatal and postnatal methylmercury exposure and neurodevelopmental outcomes
    Cox, C
    Breazna, A
    Davidson, PW
    Myers, GJ
    Clarkson, TW
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (14): : 1333 - 1334
  • [4] Neurodevelopmental outcomes in children after prenatal marijuana exposure
    Isik, Oliver G.
    Guo, Ling
    Whitehouse, Andrew J. O.
    Li, Guohua
    Ing, Caleb
    PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2023, 37 (06) : 536 - 546
  • [5] Infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use
    Labella, Madelyn H.
    Eiden, Rina D.
    Tabachnick, Alexandra R.
    Sellers, Tabitha
    Dozier, Mary
    NEUROTOXICOLOGY AND TERATOLOGY, 2021, 86
  • [6] Impact of prenatal alcohol exposure on neurodevelopmental outcomes: a systematic review
    Chu, Joanna Ting Wai
    McCormack, Jessica
    Marsh, Samantha
    Wells, Alesha
    Wilson, Holly
    Bullen, Chris
    HEALTH PSYCHOLOGY AND BEHAVIORAL MEDICINE, 2022, 10 (01): : 973 - 1002
  • [7] Early prenatal marijuana and nicotine exposure and child neurodevelopmental outcomes
    Smid, Marcela
    McMillin, Gwendolyn A.
    Metz, Torri D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S38 - S39
  • [8] Infant Health and Neurodevelopmental Outcomes Following Prenatal Exposure to Duloxetine
    Bellantuono, Cesario
    Marini, Alessandra
    Lucarelli, Chiara
    CLINICAL DRUG INVESTIGATION, 2013, 33 (09) : 685 - 688
  • [9] Prenatal Antipsychotic Exposure and Performance in Neurodevelopmental Outcomes Among Schoolchildren
    Zhang, Jingjing
    Li, Wang
    Yuan, Yuan
    JAMA INTERNAL MEDICINE, 2023, 183 (02) : 167 - 168
  • [10] Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure
    Rotem-Kohavi, Naama
    Oberlander, Tim F.
    BIRTH DEFECTS RESEARCH, 2017, 109 (12): : 909 - 923